JPY1,638.00
1.65% today
Tokyo, Aug 26, 07:52 am CET
ISIN
JP3197600004
Symbol
4528

Ono Pharmaceutical Target price 2025 - Analyst rating & recommendation

Ono Pharmaceutical Classifications & Recommendation:

Buy
5%
Hold
47%
Sell
47%

Ono Pharmaceutical Price Target

Target Price JPY1,632.00
Price JPY1,613.00
Potential
Number of Estimates 12
12 Analysts have issued a price target Ono Pharmaceutical 2026 . The average Ono Pharmaceutical target price is JPY1,632.00. This is higher than the current stock price. The highest price target is
JPY1,890.00 17.17%
register free of charge
, the lowest is
JPY1,414.00 12.34%
register free of charge
.
A rating was issued by 19 analysts: 1 Analysts recommend Ono Pharmaceutical to buy, 9 to hold and 9 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ono Pharmaceutical stock has an average upside potential 2026 of . Most analysts recommend the Ono Pharmaceutical stock at Sell or hold.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '25 2026
Estimates
Revenue Billion JPY 486.87 504.04
3.14% 3.53%
EBITDA Margin 17.80% 22.79%
45.10% 28.07%
Net Margin 10.28% 13.95%
59.62% 35.71%

13 Analysts have issued a sales forecast Ono Pharmaceutical 2026 . The average Ono Pharmaceutical sales estimate is

JPY504b
Unlock
. This is
3.53% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
JPY543b 11.45%
Unlock
, the lowest is
JPY478b 1.77%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 JPY487b 3.14%
2026
JPY504b 3.53%
Unlock
2027
JPY502b 0.32%
Unlock
2028
JPY485b 3.52%
Unlock

12 Analysts have issued an Ono Pharmaceutical EBITDA forecast 2026. The average Ono Pharmaceutical EBITDA estimate is

JPY115b
Unlock
. This is
32.60% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
JPY158b 82.39%
Unlock
, the lowest is
JPY81.3b 6.12%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 JPY86.6b 46.82%
2026
JPY115b 32.60%
Unlock
2027
JPY121b 5.72%
Unlock
2028
JPY118b 3.18%
Unlock

EBITDA Margin

2025 17.80% 45.10%
2026
22.79% 28.07%
Unlock
2027
24.17% 6.06%
Unlock
2028
24.26% 0.37%
Unlock

13 Ono Pharmaceutical Analysts have issued a net profit forecast 2026. The average Ono Pharmaceutical net profit estimate is

JPY70.3b
Unlock
. This is
40.52% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
JPY97.0b 93.91%
Unlock
, the lowest is
JPY59.6b 19.18%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 JPY50.0b 60.89%
2026
JPY70.3b 40.52%
Unlock
2027
JPY69.2b 1.66%
Unlock
2028
JPY58.0b 16.10%
Unlock

Net Margin

2025 10.28% 59.62%
2026
13.95% 35.71%
Unlock
2027
13.77% 1.29%
Unlock
2028
11.97% 13.07%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '25 2026
Estimates
Earnings Per Share JPY 106.55 149.71
60.03% 40.51%
P/E 11.13
EV/Sales 1.42

13 Analysts have issued a Ono Pharmaceutical forecast for earnings per share. The average Ono Pharmaceutical EPS is

JPY149.71
Unlock
. This is
40.55% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
JPY206.58 93.94%
Unlock
, the lowest is
JPY126.97 19.20%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 JPY106.55 60.03%
2026
JPY149.71 40.51%
Unlock
2027
JPY147.22 1.66%
Unlock
2028
JPY123.51 16.11%
Unlock

P/E ratio

Current 15.64 81.27%
2026
11.13 28.82%
Unlock
2027
11.31 1.62%
Unlock
2028
13.48 19.19%
Unlock

Based on analysts' sales estimates for 2026, the Ono Pharmaceutical stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.47 34.08%
2026
1.42 3.31%
Unlock
2027
1.43 0.32%
Unlock
2028
1.48 3.65%
Unlock

P/S ratio

Current 1.60 27.57%
2026
1.55 3.40%
Unlock
2027
1.55 0.32%
Unlock
2028
1.61 3.65%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today